SCHEMBL15977677

SCHEMBL15977677

c1ccc(-c2cc(-c3ccc4c(-c5cc6ccccc6c6ccccc56)c5ccccc5c(-c5cc6ccccc6c6ccccc56)c4c3)ccn2)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.39
CCR1 P32246 3/20 0.39
CCR5 P51681 3/20 0.39
CCR8 P51685 3/20 0.39
CYP11B1 P15538 1/20 0.38
HSP90AA1 P07900 2/20 0.38
DHODH Q02127 1/20 0.38
LMNA P02545 4/20 0.37
KDM4E B2RXH2 4/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 2/20 0.37
ALDH1A1 P00352 1/20 0.37
METAP1 P53582 2/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
BLM P54132 1/20 0.37
HIF1A Q16665 1/20 0.37
DOHH Q9BU89 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18272787 0.91 CCR1 (0.41) ADORA3CCR1CCR5CCR8CYP11B1
SCHEMBL24812248 0.89 DHODH (0.45) ADORA3CCR1CCR5CCR8CYP11B1
SCHEMBL15977794 0.88 CYP11B1 (0.40) ADORA3CCR1CCR5CCR8CYP11B1
SCHEMBL15977861 0.88 LMNA (0.40) ADORA3CYP11B1DHODHLMNAKDM4E
SCHEMBL15977919 0.84 HPGDS (0.41) ADORA3CCR1CCR5CCR8CYP11B1
SCHEMBL15977806 0.84 HPGDS (0.41) ADORA3CCR1CCR5CCR8CYP11B1
SCHEMBL15977620 0.84 MAPK1 (0.42) CCR1CCR5CCR8CYP11B1HSP90AA1
SCHEMBL15977510 0.83 KDM4E (0.40) ADORA3CCR1CCR5CCR8CYP11B1
SCHEMBL15977592 0.83 DHODH (0.42) ADORA3CCR1CCR5CCR8CYP11B1
SCHEMBL18904437 0.83 KDM4E (0.46) ADORA3CCR1CCR5CCR8CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 ADORA3 3016/4885CCR1 304/4885CCR5 1129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.